Histone deimination as a response to inflammatory stimuli in neutrophils

Journal of Immunology

Volumn 180, Issue 3, 2008, Pages 1895-1902

  Neeli, Indira ^a   Khan, Salar N ^a   Radic, Marko ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; AUTOANTIGEN; CAMPTOTHECIN; CELL NUCLEUS ANTIGEN; CITRULLINE; HISTONE H3; HYDROGEN PEROXIDE; LIPOPOLYSACCHARIDE; LIPOTEICHOIC ACID; STAUROSPORINE; TUMOR NECROSIS FACTOR; CALCIUM; HISTONE; IMINE; IONOPHORE; RETINOIC ACID;

AMINO TERMINAL SEQUENCE; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELLULAR IMMUNITY; CHROMATIN; CONTROLLED STUDY; DEGRANULATION; GRANULOCYTE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOSTIMULATION; INFLAMMATION; LEUKOCYTE ACTIVATION; NEUTROPHIL; PRIORITY JOURNAL; CELL STRAIN HL 60; CHEMISTRY; DRUG EFFECT; IMMUNOLOGY; METABOLISM;

APOPTOSIS; CALCIUM; CELL DEGRANULATION; CHROMATIN; CITRULLINE; HISTONES; HL-60 CELLS; HUMANS; IMINES; INFLAMMATION; IONOPHORES; NEUTROPHILS; TRETINOIN;

EID: 40749128547     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.180.3.1895     Document Type: Article

References (50)

1. Kouzarides, T. 2007. Chromatin modifications and their function. Cell 128: 693-705.
2. Hagiwara, T., K. Nakashima, H. Hirano, T. Senshu, and M. Yamada. 2002. Deimination of arginine residues in nucleophosmin/B23 and histones in HL-60 granulocytes. Biochem. Biophys. Res. Commun. 290: 979-983.
3. Kearney, P. L., M. Bhatia, N. G. Jones, L. Yuan, M. C. Glascock, K. L. Catchings, M. Yamada, and P. R. Thompson. 2005. Kinetic characterization of protein arginine deiminase 4: a transcriptional corepressor implicated in the onset and progression of rheumatoid arthritis. Biochemistry 44: 10570-10582.
4. Arita, K., T. Shimizu, H. Hashimoto, Y. Hidaka, M. Yamada, and M. Sato. 2006. Structural basis for histone N-terminal recognition by human peptidylarginine deiminase 4. Proc. Natl. Acad. Sci. USA 103: 5291-5296.
5. 3. J. Biol. Chem. 274: 27786-27792.
6. Cuthbert, G. L., S. Daujat, A. W. Snowden, H. Erdjument-Bromage, T. Hagiwara, M. Yamada, R. Schneider, P. D. Gregory, P. Tempst, A. J. Bannister, and T. Kouzarides. 2004. Histone deimination antagonizes arginine methylation. Cell 118: 545-553.
7. Wang, Y., J. Wysocka, J. Sayegh, Y. H. Lee, J. R. Perlin, L. Leonelli, L. S. Sonbuchner, C. H. McDonald, R. G. Cook, Y. Dou, et al. 2004. Human PAD4 regulates histone arginine methylation levels via demethylimination. Science 306: 279-283.
8. Raijmakers, R., A. J. Zendman, W. V. Egberts, E. R. Vossenaar, J. Raats, C. Soede-Huijbregts, F. P. Rutjes, P. A. van Veelen, J. W. Drijfhout, and G. J. Pruijn. 2007. Methylation of arginine residues interferes with citrullination by peptidylarginine deiminases in vitro. J. Mol Biol. 367: 1118-1129.
9. Asaga, H., K. Nakashima, T. Senshu, A. Ishigami, and M. Yamada. 2001. Immunocytochemical localization of peptidylarginine deiminase in human eosinophils and neutrophils. J. Leukocyte Biol. 70: 46-51.
10. Suzuki, A., R. Yamada, X. Chang, S. Tokuhiro, T. Sawada, M. Suzuki, M. Nagasaki, M. Nakayama-Hamada, R. Kawaida, M. Ono, et al. 2003. Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis. Nat. Genet. 34: 395-402.
11. Plenge, R. M., L. Padyukov, E. F. Remmers, S. Purcell, A. T. Lee, E. W. Karlson, F. Wolfe, D. L. Kastner, L. Alfredsson, D. Altshuler, et al. 2005. Replication of putative candidate-gene associations with rheumatoid arthritis in >4,000 samples from North America and Sweden: association of susceptibility with PTPN22, CTLA4, and PADI4. Am. J. Hum. Genet. 77: 1044-1060.
12. Yamada, R., and K. Yamamoto. 2007. Mechanisms of disease: genetics of rheumatoid arthritis-ethnic differences in disease-associated genes. Nat. Clin. Pract. Rheumatol. 3: 644-650.
13. Foulquier, C., M. Sebbag, C. Clavel, S. Chapuy-Regaud, R. Al Badine, M. C. Mechin, C. Vincent, R. Nachat, M. Yamada, H. Takahara, et al. 2007. Peptidyl arginine deiminase type 2 (PAD-2) and PAD-4 but not PAD-1, PAD-3, and PAD-6 are expressed in rheumatoid arthritis synovium in close association with tissue inflammation. Arthritis Rheum. 56: 3541-3553.
14. Lundberg, K., S. Nijenhuis, E. R. Vossenaar, K. Palmblad, W. J. van Venrooij, L. Klareskog, A. J. Zendman, and H. E. Harris. 2005. Citrullinated proteins have increased immunogenicity and arthritogenicity and their presence in arthritic joints correlates with disease severity. Arthritis Res. Ther. 7: R458-R467.
15. Nakashima, K., T. Hagiwara, and M. Yamada. 2002. Nuclear localization of peptidylarginine deiminase V and histone deimination in granulocytes. J. Biol. Chem. 277: 49562-49568.
16. Kataoka, A., M. Kubota, Y. Wakazono, A. Okuda, R. Bessho, Y. W. Lin, I. Usami, Y. Akiyama, and K. Furusho. 1995. Association of high molecular weight DNA fragmentation with apoptotic or non-apoptotic cell death induced by calcium ionophore. FEBS Lett. 364: 264-267.
17. Wang, D., K. M. Pabst, Y. Aida, and M. J. Pabst. 1995. Lipopolysaccharide-inactivating activity of neutrophils is due to lactoferrin. J. Leukocyte Biol. 57: 865-874.
18. Sergeant, S., K. A. Waite, J. Heravi, and L. C. McPhail. 2001. Phosphatidic acid regulates tyrosine phosphorylating activity in human neutrophils: enhancement of Fgr activity. J. Biol. Chem. 276: 4737-4746.
19. Radic, M., T. Marion, and M. Monestier. 2004. Nucleosomes are exposed at the cell surface in apoptosis. J. Immunol. 172: 6692-6700.
20. Simbulan-Rosenthal, C. M., D. S. Rosenthal, S. Iyer, A. H. Boulares, and M. E. Smulson. 1998. Transient poly(ADP-ribosyl)ation of nuclear proteins and role of poly(ADP-ribose) polymerase in the early stages of apoptosis. J. Biol. Chem. 273: 13703-13712.
21. Cheung, W. L., K. Ajiro, K. Samejima, M. Kloc, P. Cheung, C. A. Mizzen, A. Beeser, L. D. Etkin, J. Chernoff, W. C. Earnshaw, and C. D. Allis. 2003. Apoptotic phosphorylation of histone H2B is mediated by mammalian sterile twenty kinase. Cell 113: 507-517.
22. Kobayashi, S. D., J. M. Voyich, and F. R. DeLeo. 2003. Regulation of the neutrophil-mediated inflammatory response to infection. Microbes Infect. 5: 1337-1344.
23. Cavicchioni, G., A. Fraulini, S. Falzarano, and S. Spisani. 2006. Structure-activity relationship of for-L-Met L-Leu-L-Phe-OMe analogues in human neutrophils. Bioorg. Chem. 34: 298-318.
24. Re, F., and J. L. Strominger. 2003. Separate functional domains of human MD-2 mediate Toll-like receptor 4-binding and lipopolysaccharide responsiveness. J. Immunol. 171: 5272-5276.
25. MacEwan, D. J. 2002. TNF receptor subtype signalling: differences and cellular consequences. Cell. Signal. 14: 477-492.
26. Wehage, E., J. Eisfeld, I. Heiner, E. Jungling, C. Zitt, and A. Luckhoff. 2002. Activation of the cation channel long transient receptor potential channel 2 (LTRPC2) by hydrogen peroxide: a splice variant reveals a mode of activation independent of ADP-ribose. J. Biol. Chem. 277: 23150-23156.
27. Schroder, N. W., S. Morath, C. Alexander, L. Hamann, T. Hartung, U. Zahringer, U. B. Gobel, J. R. Weber, and R. R. Schumann. 2003. Lipoteichoic acid (LTA) of Streptococcus pneumoniae and Staphylococcus aureus activates immune cells via Toll-like receptor (TLR)-2, lipopolysaccharide-binding protein (LBP), and CD14, whereas TLR-4 and MD-2 are not involved. J. Biol. Chem. 278: 15587-15594.
28. Nathan, C. 2006. Neutrophils and immunity: challenges and opportunities. Nat. Rev. Immunol. 6: 173-182.
29. Scheel-Toellner, D., K. Wang, R. Craddock, P. R. Webb, H. M. McGettrick, L. K. Assi, N. Parkes, L. E. Clough, E. Gulbins, M. Salmon, and J. M. Lord. 2004. Reactive oxygen species limit neutrophil life span by activating death receptor signaling. Blood 104: 2557-2564.
30. Dahinden, C., C. Galanos, and J. Fehr. 1983. Granulocyte activation by endotoxin. I. Correlation between adherence and other granulocyte functions, and role of endotoxin structure on biologic activity. J. Immunol. 130: 857-862.
31. Guthrie, L. A., L. C. McPhail, P. M. Henson, and R. B. Johnston, Jr. 1984. Priming of neutrophils for enhanced release of oxygen metabolites by bacterial lipopolysaccharide: evidence for increased activity of the superoxide-producing enzyme. J. Exp. Med. 160: 1656-1671.
32. Brinkmann, V., U. Reichard, C. Goosmann, B. Fauler, Y. Uhlemann, D. S. Weiss, Y. Weinrauch, and A. Zychlinsky. 2004. Neutrophil extracellular traps kill bacteria. Science 303: 1532-1535.
33. Fuchs, T. A., U. Abed, C. Goosmann, R. Hurwitz, I. Schulze, V. Wahn, Y. Weinrauch, V. Brinkmann, and A. Zychlinsky. 2007. Novel cell death program leads to neutrophil extracellular traps. J. Cell Biol. 176: 231-241.
34. Lum, J. J., G. Bren, R. McClure, and A. D. Badley. 2005. Elimination of senescent neutrophils by TNF-related apoptosis-inducing [corrected] ligand. J. Immunol. 175: 1232-1238.
35. Colotta, F., F. Re, N. Polentarutti, S. Sozzani, and A. Mantovani. 1992. Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products. Blood 80: 2012-2020.
36. Zhang, B., J. Hirahashi, X. Cullere, and T. N. Mayadas. 2003. Elucidation of molecular events leading to neutrophil apoptosis following phagocytosis: crosstalk between caspase 8, reactive oxygen species, and MAPK/ERK activation. J. Biol. Chem. 278: 28443-28454.
37. Kobayashi, S. D., K. R. Braughton, A. R. Whitney, J. M. Voyich, T. G. Schwan, J. M. Musser, and F. R. DeLeo. 2003. Bacterial pathogens modulate an apoptosis differentiation program in human neutrophils. Proc. Natl. Acad. Sci. USA 100: 10948-10953.
38. Kobayashi, S. D., J. M. Voyich, K. R. Braughton, and F. R. DeLeo. 2003. Downregulation of proinflammatory capacity during apoptosis in human polymorphonuclear leukocytes. J. Immunol. 170: 3357-3368.
39. Lian, Z., L. Wang, S. Yamaga, W. Bonds, Y. Beazer-Barclay, Y. Kluger, M. Gerstein, P. E. Newburger, N. Berliner, and S. M. Weissman. 2001. Genomic and proteomic analysis of the myeloid differentiation program. Blood 98: 513-524.
40. Hirsch, J. G. 1958. Bactericidal action of histone. J. Exp. Med. 108: 925-944.
41. Kim, H. S., H. Yoon, I. Minn, C. B. Park, W. T. Lee, M. Zasloff, and S. C. Kim. 2000. Pepsin-mediated processing of the cytoplasmic histone H2A to strong antimicrobial peptide buforin I. J. Immunol. 165: 3268-3274.
42. Fernandes, J. M., G. D. Kemp, M. G. Molle, and V. J. Smith. 2002. Anti-microbial properties of histone H2A from skin secretions of rainbow trout, Oncorhynchus mykiss. Biochem. J. 368: 611-620.
43. Wang, Y., W. J. Griffiths, H. Jornvall, B. Agerberth, and J. Johansson. 2002. Antibacterial peptides in stimulated human granulocytes: characterization of ubiquitinated histone H1A. Eur. J. Biochem. 269: 512-518.
44. Augusto, L. A., P. Decottignies, M. Synguelakis, M. Nicaise, P. Le Marechal, and R. Chaby. 2003. Histones: a novel class of lipopolysaccharide- binding molecules. Biochemistry 42: 3929-3938.
45. Dennison, S. R., J. Wallace, F. Harris, and D. A. Phoenix. 2005. Amphiphilic α-helical antimicrobial peptides and their structure/function relationships. Protein Pept. Lett. 12: 31-39.
46. Luger, K., A. W. Mader, R. K. Richmond, D. F. Sargent, and T. J. Richmond. 1997. Crystal structure of the nucleosome core particle at 2.8 A resolution. Nature 389: 251-260.
47. Verdel, A., S. Jia, S. Gerber, T. Sugiyama, S. Gygi, S. I. Grewal, and D. Moazed. 2004. RNAi-mediated targeting of heterochromatin by the RITS complex. Science 303: 672-676.
48. Erlandsson Harris, H., and U. Andersson. 2004. Mini-review: The nuclear protein HMGB1 as a proinflammatory mediator. Eur. J. Immunol. 34: 1503-1512.
49. Scaffidi, P., T. Misteli, and M. E. Bianchi. 2002. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 418: 191-195.
50. Jiang, W., and D. S. Pisetsky. 2006. The role of IFN-α and nitric oxide in the release of HMGB1 by RAW 264.7 cells stimulated with polyinosinic-polycytidylic acid or lipopolysaccharide. J. Immunol. 177: 3337-3343.